Allergan Plc (AGN) 326.98 $AGN Business Highlig
Post# of 273327
Posted On: 07/28/2015 12:09:47 AM
Allergan Plc (AGN) 326.98 $AGN
Business Highlights
By The Associated Press - AP - Mon Jul 27, 5:12PM CDT
___
AGN: 326.98 (+18.77), QSR: 41.50 (+1.41), F: 14.55 (+0.16), QSR.TO: 54.21 (+2.01), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15), MHFI: 99.59 (-5.99)
Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid
at The Street - Mon Jul 27, 4:47PM CDT
Pharmaceutical giant Mylan (MYL) was the worst performing stock in the S&P 500 on Monday, making it TheStreet's Move of the Day.
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA
GlobeNewswire - Mon Jul 27, 4:45PM CDT
Allergan plc (NYSE:AGN) and KYTHERA Biopharmaceuticals, Inc. (NASDAQ:KYTH) today announced that the U.S. Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Allergan's pending acquisition of KYTHERA.
AGN: 326.98 (+18.77), KYTH: 74.35 (+0.18)
Analysts expect more tie-ups in generic drug business
AP - Mon Jul 27, 3:43PM CDT
NEW YORK (AP) — Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
1 Comment
IPXL: 49.25 (+0.04), AGN: 326.98 (+18.77), AKRX: 46.16 (+0.77), SGNT: 25.48 (+0.22), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
Stocks Fall For Fifth Straight Session On China Woes
at Investor's Business Daily - Mon Jul 27, 3:39PM CDT
Stocks fell for the fifth straight session Monday as a sell-off in China's main index sparked fears of a slowdown in the world's second-biggest economy. The Nasdaq fell 1%, sliding below its 50-day moving average. The Dow Jones industrial average...
AGN: 326.98 (+18.77), NFX: 30.88 (-1.90), CYBR: 59.83 (-3.18), SOHU: 42.74 (-1.94), TEVA: 72.00 (+10.15), MRO: 20.69 (-0.72), JD: 32.15 (-2.49), PAYC: 31.60 (-2.15), BABA: 81.40 (-1.62)
Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash
at The Street - Mon Jul 27, 3:30PM CDT
People are "max negative" on Twitter ahead of its earnings report Tuesday, which Jim Cramer doesn't see as unjustified -- at least, in the short term.
AGN: 326.98 (+18.77), BIIB: 309.43 (+9.40), GILD: 110.54 (-2.29), TEVA: 72.00 (+10.15), TWTR: 34.70 (-0.72)
Stocks Down in the Dumps as Chinese Market Slumps
at The Street - Mon Jul 27, 3:05PM CDT
Wall Street sees no fresh start to the week as stocks suffer their fifth day of losses on Monday.
KMI: 35.22 (+0.37), COP: 50.65 (-1.44), FCAU: 14.41 (-0.74), UBS: 21.98 (-0.34), SLB: 81.76 (-1.14), AGN: 326.98 (+18.77), QCOM: 61.98 (+0.34), DANG: 6.54 (-0.18), TEVA: 72.00 (+10.15), BP: 36.05 (-0.52), JD: 32.15 (-2.49), CVX: 89.14 (-1.46), PTR: 95.17 (-4.75), XLE: 68.51 (-1.00), BABA: 81.40 (-1.62)
Stocks Extend Losing Streak as Oil Closes Below $48
at The Street - Mon Jul 27, 2:12PM CDT
Stocks spend their fifth day in the red on Monday, their longest longest streak in six months.
KMI: 35.22 (+0.37), DAL: 43.93 (-0.17), CEA: 44.34 (-3.08), COP: 50.65 (-1.44), FCAU: 14.41 (-0.74), UBS: 21.98 (-0.34), SLB: 81.76 (-1.14), AGN: 326.98 (+18.77), QCOM: 61.98 (+0.34), DANG: 6.54 (-0.18), TEVA: 72.00 (+10.15), BP: 36.05 (-0.52), JD: 32.15 (-2.49), CVX: 89.14 (-1.46), PTR: 95.17 (-4.75), XLE: 68.51 (-1.00), BABA: 81.40 (-1.62)
Is the U.S. Bull Market Starting to Lose Its Luster?
at The Street - Mon Jul 27, 2:04PM CDT
CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.
BIIB: 309.43 (+9.40), PRGO: 193.60 (+7.10), XOM: 79.26 (-0.68), MYL: 56.37 (-9.57), BMY: 64.30 (-1.68), AGN: 326.98 (+18.77), ISRG: 544.15 (-1.93), SBUX: 56.98 (-0.31), HCA: 92.03 (-0.80), IBM: 159.07 (-0.68), GM: 31.05 (-0.01), TEVA: 72.00 (+10.15), SPLK: 70.60 (-3.31), REGN: 540.03 (-1.82), NVS: 101.54 (-0.26)
3 Health Care Stocks to Trade for Gains
at The Street - Mon Jul 27, 12:56PM CDT
Here's a technical look at how to trade some of the most active stocks on the market right now.
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
Stocks Mired In Red, Hurt By China Weakness; Boot Barn Bounces
at Investor's Business Daily - Mon Jul 27, 12:37PM CDT
Stocks were back near session lows in early afternoon trading Monday, weighed down by an 8.5% drop in the Shanghai composite overnight as well as weakness in Europe. The Nasdaq lost 0.9%, the Dow Jones industrial average gave up 0.7% and the S&P 500...
AGN: 326.98 (+18.77), BIDU: 197.68 (-8.57), BOOT: 31.44 (+0.61), TEVA: 72.00 (+10.15), BA: 141.03 (-3.03)
Cramer's Charitable Trust: We Love This Possible Allergan Deal
at The Street - Mon Jul 27, 11:30AM CDT
And we are raising our price target on AGN.
AGN: 326.98 (+18.77), TEVA: 72.00 (+10.15)
Stocks In The Red But Off Lows As Shanghai, Europe Weigh
at Investor's Business Daily - Mon Jul 27, 10:57AM CDT
U.S. stocks were under pressure near midday Monday, brought on by an 8.5% drop in the Shanghai composite overnight as well as weakness in Europe. The Dow Jones industrial average and Nasdaq lost 0.8% while the S&P 500 shed 0.5%. Volume on both main...
BID: 41.23 (-0.53), VR: 45.29 (-0.21), ENTA: 47.47 (+2.28), AGN: 326.98 (+18.77), LOGM: 73.17 (+0.96), FFIV: 127.81 (+0.32), TEVA: 72.00 (+10.15), WAB: 97.93 (+6.59), X: 16.80 (+0.55)
Teva Pharmaceutical to Buy Allergan's Generics Unit in $40.5 Billion Deal - Stocks in the News
Madeleine Johnson - Zacks Investment Research - Mon Jul 27, 10:53AM CDT
Teva Pharmaceutical Industries has agreed to acquire Allergan Plc’s generic drug sector for roughly $40.5 billion.
AGN: 326.98 (+18.77), TEVA: 72.00 (+10.15)
Why Teva Pharmaceutical Industries Ltd. Stock Jumped Today
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 10:04AM CDT
What : Shares of the generic drugmaker Teva Pharmaceutical Industries Ltd. rose by 11% in early morning trading after the company announced that it plans on buying Allergan 's generic drug business in a cash and stock deal worth a reported $40.5...
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China
PR Newswire - Mon Jul 27, 10:04AM CDT
Bloomage BioTechnology Corporation Limited ("Bloomage" or "The Company", Stock Code: 00963.HK) announces a strategic cooperation with the South Korean BioTech Company Medytox Inc. ("Medytox", Stock Code: 086900.KS) to establish a joint venture Medybloom to develop and promote Type A Botulinum Toxin ("Botulinum Toxin"
business in China.
AGN: 326.98 (+18.77)
Stocks Remain in Red After Chinese Market Slump
at The Street - Mon Jul 27, 9:37AM CDT
Stocks trade lower Monday morning in response to a massive, inexplicable selloff in Chinese equities.
AGN: 326.98 (+18.77), QCOM: 61.98 (+0.34), BBY: 32.06 (-0.40), TEVA: 72.00 (+10.15), FCAU: 14.41 (-0.74), UBS: 21.98 (-0.34), MHFI: 99.59 (-5.99), AAPL: 122.77 (-1.73)
Allergan (AGN) Stock Rises After $40.5 Billion Generic Drug Business Sale
at The Street - Mon Jul 27, 9:10AM CDT
Allergan (AGN) shares are climbing after the company sold its generic drug business to Teva for $40.5 billion today.
AGN: 326.98 (+18.77)
Teva Confirms Allergan Generics Buy, Drops Mylan Bid
at Investor's Business Daily - Mon Jul 27, 8:10AM CDT
Teva Pharmaceutical (TEVA) confirmed reports Monday that it will buy Allergan's (AGN) generic drugs business for $40.5 billion and dropped its hostile takeover bid for Mylan Pharmaceuticals (MYL). Under the deal, Teva will pay $33.75 billion in cash...
AGN: 326.98 (+18.77), PRGO: 193.60 (+7.10), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
Business Highlights
By The Associated Press - AP - Mon Jul 27, 5:12PM CDT
___
AGN: 326.98 (+18.77), QSR: 41.50 (+1.41), F: 14.55 (+0.16), QSR.TO: 54.21 (+2.01), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15), MHFI: 99.59 (-5.99)
Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid
at The Street - Mon Jul 27, 4:47PM CDT
Pharmaceutical giant Mylan (MYL) was the worst performing stock in the S&P 500 on Monday, making it TheStreet's Move of the Day.
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
Allergan and KYTHERA Announce Early Termination of Hart-Scott-Rodino Waiting Period for Allergan's Pending Acquisition of KYTHERA
GlobeNewswire - Mon Jul 27, 4:45PM CDT
Allergan plc (NYSE:AGN) and KYTHERA Biopharmaceuticals, Inc. (NASDAQ:KYTH) today announced that the U.S. Federal Trade Commission (FTC) has granted early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR Act) with respect to Allergan's pending acquisition of KYTHERA.
AGN: 326.98 (+18.77), KYTH: 74.35 (+0.18)
Analysts expect more tie-ups in generic drug business
AP - Mon Jul 27, 3:43PM CDT
NEW YORK (AP) — Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
1 Comment
IPXL: 49.25 (+0.04), AGN: 326.98 (+18.77), AKRX: 46.16 (+0.77), SGNT: 25.48 (+0.22), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
Stocks Fall For Fifth Straight Session On China Woes
at Investor's Business Daily - Mon Jul 27, 3:39PM CDT
Stocks fell for the fifth straight session Monday as a sell-off in China's main index sparked fears of a slowdown in the world's second-biggest economy. The Nasdaq fell 1%, sliding below its 50-day moving average. The Dow Jones industrial average...
AGN: 326.98 (+18.77), NFX: 30.88 (-1.90), CYBR: 59.83 (-3.18), SOHU: 42.74 (-1.94), TEVA: 72.00 (+10.15), MRO: 20.69 (-0.72), JD: 32.15 (-2.49), PAYC: 31.60 (-2.15), BABA: 81.40 (-1.62)
Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash
at The Street - Mon Jul 27, 3:30PM CDT
People are "max negative" on Twitter ahead of its earnings report Tuesday, which Jim Cramer doesn't see as unjustified -- at least, in the short term.
AGN: 326.98 (+18.77), BIIB: 309.43 (+9.40), GILD: 110.54 (-2.29), TEVA: 72.00 (+10.15), TWTR: 34.70 (-0.72)
Stocks Down in the Dumps as Chinese Market Slumps
at The Street - Mon Jul 27, 3:05PM CDT
Wall Street sees no fresh start to the week as stocks suffer their fifth day of losses on Monday.
KMI: 35.22 (+0.37), COP: 50.65 (-1.44), FCAU: 14.41 (-0.74), UBS: 21.98 (-0.34), SLB: 81.76 (-1.14), AGN: 326.98 (+18.77), QCOM: 61.98 (+0.34), DANG: 6.54 (-0.18), TEVA: 72.00 (+10.15), BP: 36.05 (-0.52), JD: 32.15 (-2.49), CVX: 89.14 (-1.46), PTR: 95.17 (-4.75), XLE: 68.51 (-1.00), BABA: 81.40 (-1.62)
Stocks Extend Losing Streak as Oil Closes Below $48
at The Street - Mon Jul 27, 2:12PM CDT
Stocks spend their fifth day in the red on Monday, their longest longest streak in six months.
KMI: 35.22 (+0.37), DAL: 43.93 (-0.17), CEA: 44.34 (-3.08), COP: 50.65 (-1.44), FCAU: 14.41 (-0.74), UBS: 21.98 (-0.34), SLB: 81.76 (-1.14), AGN: 326.98 (+18.77), QCOM: 61.98 (+0.34), DANG: 6.54 (-0.18), TEVA: 72.00 (+10.15), BP: 36.05 (-0.52), JD: 32.15 (-2.49), CVX: 89.14 (-1.46), PTR: 95.17 (-4.75), XLE: 68.51 (-1.00), BABA: 81.40 (-1.62)
Is the U.S. Bull Market Starting to Lose Its Luster?
at The Street - Mon Jul 27, 2:04PM CDT
CNBC’s ‘Fast Money’ traders take a closer look at U.S. stocks, as the selloff in China weighs on the market.
BIIB: 309.43 (+9.40), PRGO: 193.60 (+7.10), XOM: 79.26 (-0.68), MYL: 56.37 (-9.57), BMY: 64.30 (-1.68), AGN: 326.98 (+18.77), ISRG: 544.15 (-1.93), SBUX: 56.98 (-0.31), HCA: 92.03 (-0.80), IBM: 159.07 (-0.68), GM: 31.05 (-0.01), TEVA: 72.00 (+10.15), SPLK: 70.60 (-3.31), REGN: 540.03 (-1.82), NVS: 101.54 (-0.26)
3 Health Care Stocks to Trade for Gains
at The Street - Mon Jul 27, 12:56PM CDT
Here's a technical look at how to trade some of the most active stocks on the market right now.
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
Stocks Mired In Red, Hurt By China Weakness; Boot Barn Bounces
at Investor's Business Daily - Mon Jul 27, 12:37PM CDT
Stocks were back near session lows in early afternoon trading Monday, weighed down by an 8.5% drop in the Shanghai composite overnight as well as weakness in Europe. The Nasdaq lost 0.9%, the Dow Jones industrial average gave up 0.7% and the S&P 500...
AGN: 326.98 (+18.77), BIDU: 197.68 (-8.57), BOOT: 31.44 (+0.61), TEVA: 72.00 (+10.15), BA: 141.03 (-3.03)
Cramer's Charitable Trust: We Love This Possible Allergan Deal
at The Street - Mon Jul 27, 11:30AM CDT
And we are raising our price target on AGN.
AGN: 326.98 (+18.77), TEVA: 72.00 (+10.15)
Stocks In The Red But Off Lows As Shanghai, Europe Weigh
at Investor's Business Daily - Mon Jul 27, 10:57AM CDT
U.S. stocks were under pressure near midday Monday, brought on by an 8.5% drop in the Shanghai composite overnight as well as weakness in Europe. The Dow Jones industrial average and Nasdaq lost 0.8% while the S&P 500 shed 0.5%. Volume on both main...
BID: 41.23 (-0.53), VR: 45.29 (-0.21), ENTA: 47.47 (+2.28), AGN: 326.98 (+18.77), LOGM: 73.17 (+0.96), FFIV: 127.81 (+0.32), TEVA: 72.00 (+10.15), WAB: 97.93 (+6.59), X: 16.80 (+0.55)
Teva Pharmaceutical to Buy Allergan's Generics Unit in $40.5 Billion Deal - Stocks in the News
Madeleine Johnson - Zacks Investment Research - Mon Jul 27, 10:53AM CDT
Teva Pharmaceutical Industries has agreed to acquire Allergan Plc’s generic drug sector for roughly $40.5 billion.
AGN: 326.98 (+18.77), TEVA: 72.00 (+10.15)
Why Teva Pharmaceutical Industries Ltd. Stock Jumped Today
George Budwell, The Motley Fool - Motley Fool - Mon Jul 27, 10:04AM CDT
What : Shares of the generic drugmaker Teva Pharmaceutical Industries Ltd. rose by 11% in early morning trading after the company announced that it plans on buying Allergan 's generic drug business in a cash and stock deal worth a reported $40.5...
AGN: 326.98 (+18.77), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
Bloomage (00963.HK) and Medytox Inc. set up a Joint Venture To Jointly Develop Botulinum Toxin Market in China
PR Newswire - Mon Jul 27, 10:04AM CDT
Bloomage BioTechnology Corporation Limited ("Bloomage" or "The Company", Stock Code: 00963.HK) announces a strategic cooperation with the South Korean BioTech Company Medytox Inc. ("Medytox", Stock Code: 086900.KS) to establish a joint venture Medybloom to develop and promote Type A Botulinum Toxin ("Botulinum Toxin"
business in China. AGN: 326.98 (+18.77)
Stocks Remain in Red After Chinese Market Slump
at The Street - Mon Jul 27, 9:37AM CDT
Stocks trade lower Monday morning in response to a massive, inexplicable selloff in Chinese equities.
AGN: 326.98 (+18.77), QCOM: 61.98 (+0.34), BBY: 32.06 (-0.40), TEVA: 72.00 (+10.15), FCAU: 14.41 (-0.74), UBS: 21.98 (-0.34), MHFI: 99.59 (-5.99), AAPL: 122.77 (-1.73)
Allergan (AGN) Stock Rises After $40.5 Billion Generic Drug Business Sale
at The Street - Mon Jul 27, 9:10AM CDT
Allergan (AGN) shares are climbing after the company sold its generic drug business to Teva for $40.5 billion today.
AGN: 326.98 (+18.77)
Teva Confirms Allergan Generics Buy, Drops Mylan Bid
at Investor's Business Daily - Mon Jul 27, 8:10AM CDT
Teva Pharmaceutical (TEVA) confirmed reports Monday that it will buy Allergan's (AGN) generic drugs business for $40.5 billion and dropped its hostile takeover bid for Mylan Pharmaceuticals (MYL). Under the deal, Teva will pay $33.75 billion in cash...
AGN: 326.98 (+18.77), PRGO: 193.60 (+7.10), MYL: 56.37 (-9.57), TEVA: 72.00 (+10.15)
(0)
(0)